Keros Therapeutics will use the Massachusetts General Hospital MyMatch program to design a clinical trial testing rinvatercept for ALS.

Columnist Juliet Taylor reflects on the legacy of Leah Stavenhagen, who founded Her ALS Story for young women diagnosed with the disease.

Hearing how a family found meaning in the midst of their loss reminds columnist Kristin Neva that she isn't alone in her grief with ALS.

Insmed has launched a first-in-human Phase 1 trial testing its experimental ALS gene therapy INS1202 in people with the disease.

ALS News Today joins the ALS Network’s ASK ME ALS webinar series as presenting sponsor, offering expert discussions on ALS ...

For columnist Dagmar Munn, reducing uncertainty in one area of her life with ALS would mean keeping her ALS progression right where it is.

The president and CEO of the Muscular Dystrophy Association talks about what she's most excited about in neuromuscular ...

Experimental therapy RT1999 will soon be tested in the UK EXPERTS-ALS platform trial designed to rapidly screen potential ALS treatments.

Dosing has begun in a new regimen of the HEALEY ALS platform trial, its ninth, which is testing the oral therapy NUZ-001 for ...

Clinical & Scientific Conference, researchers and clinicians are talking about the central role of patients, families, and caregivers in driving change for people living with neuromuscular diseases.

AB Science says a newly identified blood biomarker may help assess masitinib activity in its ongoing Phase 3 ALS clinical ...

Chris was diagnosed with ALS in 2024. Before that, he spent 40 years in the oil and gas industry, working and living in eight countries across five continents. He’s dedicated himself to helping others ...